MDMA therapy inches closer to approval
PTSD affects about 5 percent of the adult population of the United States each year… federal approval for MDMA-assisted therapy would also mean the drug would have to receive a less serious ranking for controlled substances by the D.E.A. and from states.
MDMA-assisted therapy seems to be effective in reducing symptoms of post-traumatic stress disorder, according to a study published on Thursday [9/14/23]. The research is the final trial conducted by MAPS Public Benefit Corporation, a company that is developing prescription psychedelics. It plans to submit the results to the Food and Drug Administration as part of an application for approval to market MDMA, the psychedelic drug, as a treatment for PTSD, when paired with talk therapy…
Original Article (New York Times):
MDMA therapy inches closer to approval
Artwork Fair Use: 5-HT2AR
